TransMedics (TMDX) Price to Sales (2019 - 2026)

TransMedics has reported Price to Sales for 8 years, with the latest figure at 12.11 in Q2 2026.

• On a quarterly basis, Price to Sales fell 58.23% year-over-year to 12.11 in Q2 2026; TTM through Jun 2026 was 3.44, a 59.92% decrease from a year earlier, with the FY2025 full-year figure at 6.88, up 45.03% from the prior year.
• Price to Sales was 12.11 for Q2 2026 at TransMedics, down from 19.74 in the prior quarter.
• The five-year high for Price to Sales was 63.23 in Q4 2022, with the low at 12.11 in Q2 2026.
• Average Price to Sales over 5 years is 35.53, with a median of 30.38 recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Price to Sales sank 69.42% in 2022, then jumped 80.08% in 2024.
• Over 5 years, Price to Sales stood at 63.23 in 2022, then slumped by 49.76% to 31.77 in 2023, then slumped by 45.75% to 17.23 in 2024, then jumped by 50.46% to 25.93 in 2025, then slumped by 53.3% to 12.11 in 2026.
• The last three Price to Sales figures came in at 12.11 (Q2 2026), 19.74 (Q1 2026), and 25.93 (Q4 2025), per Business Quant data.